We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Immunoassay Developed for Histoplasmosis Diagnosis

By LabMedica International staff writers
Posted on 27 Jan 2011
An immunoassay, using purified deglycosylated antigen, has been developed to diagnose different manifestations of the fungal disease histoplasmosis. More...


The enzyme-linked immunosorbent assay (ELISA) detects antibodies to Histoplasma capsulatum, the causative agent of histoplasmosis, using metaperiodate treated purified histoplasmin (ptHMIN), the specific antigen of this fungus.

To evaluate the ELISA test clinical serum samples were selected randomly from the Immunodiagnostic Section Serum Bank, Laboratory of Mycology, Institute of Clinical Research Evandro Chagas, (Fiocruz; Rio de Janeiro, Brazil). Forty-four sera samples were tested from homologous histoplasmosis and 35 sera samples from other cases of mycoses. These included seven with paraccocidioidomycosis; eight for each of the following: aspergillosis sporotrichosis, and cryptococcosis cases, and four from coccidioidomycosis patients. Additionally, 36 negative control sera from healthy donors were collected and tested.

The results of the assay showed that the optical densities (ODs) were significantly higher in sera from 44 patients with histoplasmosis than in heterologous-infected samples evaluated. Differences in the means and comparisons of parameters indicate that the test effectively discriminates between negative and positive samples. The distribution of OD values varied in the clinical groups, but no statistical differences were found between them. The OD values are an indication of antibody levels in the patients' sera.

The overall test specificity was 96%, with sensitivities of 100% in acute disease, 90% in chronic disease, 86% in disseminated disease co-infected with Human Immunodeficiency Virus (HIV), 89% in disseminated infection in individuals without HIV infection, and 100% in mediastinal histoplasmosis. The authors of the study concluded that the high specificities, sensitivities, and simplicity of the ELISA support further development of a deglycosylated HMIN ELISA for clinical use and for monitoring the humoral immune response during therapy in patients with chronic and disseminated histoplasmosis.

Histoplasmosis is a disease caused when airborne spores of the fungus H. capsulatum are inhaled into the lungs, the primary infection site. This microscopic fungus, which is found throughout the world in river valleys and soil where bird or bat droppings accumulate, is released into the air when soil is disturbed by plowing fields, sweeping chicken coops, or digging holes. The clinical disease generally ranges from mild influenza-like illnesses to progressive, disseminated disease, which manifests mostly in immunocompromised individuals. The study was published on line on January 4, 2010, in the open access journal Microbiology Research.

Related Links:

Institute of Clinical Research Evandro Chagas





Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Aspiration System
VACUSAFE
Electrolyte Analyzer
BKE-B
New
Nucleic Acid Purification Instrument
QIAsymphony Connect
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: 123RF

Screening After Pneumococcal Disease May Reveal Undiagnosed Blood Cancer or Immune Disorders

Severe pneumococcal disease requiring hospitalization often presents as pneumonia, particularly in older adults and people with cancer or compromised immune function. Because M protein testing and antibody... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.